Fish sourcing and allergy
The material comes from fish and the purification is designed to remove the proteins that cause fish allergy. That is a reassurance with a basis, and it is not a guarantee.

Polynucleotide products are in the great majority fish derived, most commonly from salmon or trout. Fish allergy is caused by fish proteins, principally parvalbumin, and the manufacturing process is specifically designed to remove protein from the extract. On that basis manufacturers describe the products as suitable for people with fish allergy, and reactions attributable to fish protein appear to be uncommon.
What is missing is the surveillance that would turn appears to be uncommon into a supported statement. Reporting in this sector is voluntary and incomplete. If you have a fish allergy, particularly one that has produced a significant reaction, this belongs in a conversation with a clinician before the day of treatment, and it belongs in your notes.
4.3.1What fish allergy is
Fish allergy is an immune response to specific proteins in fish tissue. Parvalbumin is the principal one and it is heat stable, which is why cooking does not remove the allergen. Reactions range from mild to anaphylactic, and the severity of previous reactions is the best available guide to what a future one might look like, though it is not a reliable predictor. The NHS pages on allergies and on anaphylaxis are the correct starting points and they are written for patients rather than clinicians.
Two points are commonly confused in consultations. Fish allergy and shellfish allergy are different allergies to different proteins in different animals, and someone allergic to prawns is not thereby allergic to salmon. And allergy is not intolerance: a person who feels unwell after eating fish does not necessarily have an allergy, and someone who does have one should know it from proper assessment rather than from inference.
4.3.2What purification is designed to do
The extraction and purification process is aimed at isolating nucleic acid from everything else in the source tissue. Protein removal is central to it, both because protein is the allergen and because protein contamination in an injectable is an immunological risk in its own right. The process also targets endotoxin and microbial material, since the product is injected.
The result is a preparation in which residual protein is intended to be at a level too low to provoke a response. That is the manufacturer's specification and it is a reasonable one. What a patient cannot do is verify it, because batch level residual protein data is not published in a form available to the public.
4.3.3Why the absence of reports is weaker evidence than it sounds
A common line in consultations is that reactions have not been reported. This is probably accurate and it is a weaker reassurance than it appears, for a structural reason.
Private cosmetic practice in the United Kingdom has no mandatory adverse event reporting. The MHRA Yellow Card scheme covers medical devices and accepts reports from clinicians and from the public, but it is voluntary. There is no national register of procedures. A clinic experiencing an adverse event has no obligation to report it and has a commercial reason not to advertise it. In that environment, the absence of reports tells you considerably less than it would in a setting with mandatory reporting and a denominator.
None of this means reactions are occurring and being hidden. It means the reassurance rests on a surveillance system that would struggle to detect an uncommon event.
| What to disclose | Why |
|---|---|
| A diagnosed fish allergy, and how it was diagnosed | The product is fish derived; purification is designed to remove the allergen but you should be assessed rather than reassured |
| Your worst previous reaction | Severity history informs how much caution is warranted |
| Any history of anaphylaxis to anything | Changes the risk calculation for every elective injectable and determines what emergency provision is needed |
| Whether you carry adrenaline auto injectors | So they are present and known about |
| Whether you avoid animal derived products for non medical reasons | Because you are entitled to know the origin before consenting, not afterwards |
A framework written by this publication to organise a decision. It is not a measurement, it is not drawn from any study, and no figure in it should be quoted as a finding.
4.3.4How to raise it
Raise it at consultation, not in the treatment room. Be specific about what you are allergic to, how it was diagnosed, and what your worst reaction has been. Ask the practitioner what the manufacturer's instructions for use say about fish allergy, and ask for the answer from the document rather than from memory.
Ask for the conversation to be recorded in your notes. That is not a legal manoeuvre; it is how a clinical record is supposed to work, and it means that if you see a different clinician later, the information travels with you.
If you carry adrenaline auto injectors, bring them. If you have had anaphylaxis to anything, ask what emergency provision the clinic has and who is trained to use it. That question is a reasonable one to ask before any injectable procedure and it is answered well by good practices without any awkwardness.
4.3.5Beyond allergy: the other reasons sourcing matters
People decline animal derived products for reasons that are not medical, and a consent process that does not surface the origin of the material has failed on its own terms. Vegetarian and vegan patients, patients whose religious practice restricts animal products, and patients who simply prefer not to, all have a legitimate interest in being told before rather than after.
The right time to say so is the consultation, and the right question is simply what the product is made from. It should not require a patient to know in advance that the answer is fish.
4.3.6If it is not for you
We are not aware of an established plant derived or synthetic polynucleotide injectable in routine UK cosmetic use. If you are offered one, ask what the product is, who manufactures it, and whether it carries a UKCA or CE mark, and treat vagueness on those points as significant.
If a fish derived product is not acceptable to you, that is a complete answer and requires no further justification. Other categories of injectable exist that are not animal derived, hyaluronic acid produced by bacterial fermentation among them, and the article comparing regenerative injectables sets out what each one is and is not.
Questions
I am allergic to fish. Can I have this treatment?
That is a question for a clinician who knows your allergy history, and it should be raised at consultation rather than on the day. Ask what the manufacturer's instructions for use say, ask for the answer from the document, and ask for the discussion to be recorded in your notes.
Is shellfish allergy the same thing?
No. Fish allergy and shellfish allergy involve different proteins in different animals and are frequently confused in consultations. Say precisely what you are allergic to rather than describing a category.
If purification removes the protein, why is this still a discussion?
Because the specification is the manufacturer's, batch level residual protein data is not public, and the reassurance that no reactions have been reported comes from a voluntary reporting system that would struggle to detect an uncommon event. The reasoning is sound; the verification is not available to you.
Is there a vegan alternative?
We are not aware of an established plant derived or synthetic polynucleotide injectable in routine UK cosmetic use. Other injectable categories are not animal derived, including hyaluronic acid made by bacterial fermentation, which is a different treatment with a different rationale.
Should the clinic tell me it comes from fish without my asking?
Yes. The origin of an injected material is plainly relevant to consent, for medical reasons and for reasons of belief and diet. A consultation that leaves you to discover it afterwards has not done its job.
- NHS, Allergies
- NHS, Anaphylaxis
- MHRA Yellow Card scheme
- Medical devices: regulation and safety, gov.uk
- NHS, Cosmetic procedures
Links to regulators, professional bodies, legislation and research indexes. They are cited because they are public and checkable, not as endorsement of this publication. No source listed here has any commercial relationship with us.
Revisions to this document
This reference is revised when the evidence changes. Subscribe and you will be told what was revised, what the verdict was before, and what it is now.
One email when this document is revised, with what changed and why. Any sponsor line is labelled as such and can never influence an evidence verdict. Rates are published on the newsletter page. We do not sell, share or rent the list. Unsubscribe from any email.